For the next few weeks, we're going to highlight one of Schaeffer's top 15 picks for 2026.
Cameco (CCJ) reached $119.11 at the closing of the latest trading day, reflecting a +2.63% change compared to its last close.
Market volatility has created strong buying opportunities in several stocks. Cameco has been on an incredible bull run supplying the nuclear renaissance, and it has stalled out.
When deciding whether to buy, sell, or hold a stock, investors often rely on analyst recommendations. Media reports about rating changes by these brokerage-firm-employed (or sell-side) analysts often influence a stock's price, but are they really important?
CCJ rides nuclear tailwinds with strong earnings growth and long-term contracts, but a rich valuation and softer 2026 outlook raise entry timing questions.
Cameco is rated 'Buy,' leveraging its strategic market management and disciplined contract approach amid a bullish uranium cycle. CCJ's integrated model—mining, fuel conversion, and reactor services—positions it for robust, diversified revenue growth as uranium prices and reactor builds accelerate. Despite appearing overvalued on traditional metrics, the company's low-cost production, high-grade mines, and inventory at favorable costs underpin superior profitability.
Cameco (CCJ) closed the most recent trading day at $111.13, moving +2.32% from the previous trading session.
The latest trading day saw Cameco (CCJ) settling at $104.67, representing a -3.99% change from its previous close.
CCJ stands out against UEC with stronger earnings visibility, contracts and valuation, positioning the former as the more compelling uranium play.
The recommendations of Wall Street analysts are often relied on by investors when deciding whether to buy, sell, or hold a stock. Media reports about these brokerage-firm-employed (or sell-side) analysts changing their ratings often affect a stock's price.
Cameco (CCJ) closed the most recent trading day at $106.6, moving 2.56% from the previous trading session.
Cameco posts 11% revenue growth in 2025, but volume declines and a softer uranium outlook point to a projected sales dip in 2026.